European Healthtech startup funding raised during 2012.
In 2012, 70 European Healthtech companies raised a combined €490M across 74 funding rounds. UK led by capital raised, and Amadeus Capital Partners was the most active investor. Data as of 7 Aug 2026.
1 exit.
| Dec 2012 |
| €35M |
| Endosense | Series C | Nov 2012 | €31M |
| F2G | Growth/Late | Sep 2012 | €27M |
| Cell Medica | Other | Jul 2012 | €24M |
| GenKyoTex | Series C | Jul 2012 | €21M |
| NeRRe Therapeutics | Series A | Dec 2012 | €14M |
| EarlySense | Series D+ | Nov 2012 | €12M |
| Egalet | Series B | May 2012 | €11M |
| GlySure | Series C | Nov 2012 | €10M |
| GlySure | Series C | Jan 2012 | €8.4M |
| Pharnext | Other | Feb 2012 | €8.0M |
| CartiHeal | Early VC | Jul 2012 | €7.9M |
